Summary & Overview
CPT 55705: Non–Image-Guided Prostate Tissue Biopsy
CPT code 55705 covers non–image-guided prostate tissue sampling performed to diagnose or evaluate prostate cancer and other prostatic disease. Nationally, this CPT code represents a common urologic diagnostic procedure that affects surgical practice patterns, billing workflows, and payer coverage determinations. Accurate coding for 55705 matters for clinical documentation, resource utilization tracking, and claims adjudication.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what 55705 represents clinically, how it is typically delivered (service settings and provider specialty), and an overview of the billing context. The publication also summarizes typical modifiers observed with this service and highlights related policy and coverage considerations that influence reimbursement and prior authorization practices.
This summary provides clinicians, billing professionals, and policy analysts with benchmarks for coding practice, common payer considerations, and the clinical context for non–image-guided prostate biopsy. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 55705 describes a procedure in which the provider collects prostate tissue samples without the use of imaging guidance. The procedure is performed to evaluate for prostate cancer or other prostatic disease. This code applies to any surgical approach used to obtain the tissue samples.
-
Service type: Prostate tissue biopsy without imaging guidance
-
Typical site of service: Ambulatory surgical center or hospital outpatient setting; office-based procedures may also be performed depending on clinical context
Clinical & Coding Specifications
Clinical Context
A 63-year-old male presents to the urology clinic with an elevated prostate-specific antigen (PSA) level of 8.2 ng/mL and a suspicious digital rectal exam finding of a firm nodule in the peripheral zone of the prostate. After informed consent and pre-procedure assessment, the urologist performs a transrectal, non-image-guided prostate needle biopsy to obtain multiple tissue cores for histopathologic evaluation for prostate cancer. The procedure is often performed in an ambulatory surgical center or hospital outpatient department under local anesthesia with or without sedation. Typical workflow: pre-procedure verification and consent, topical or local anesthesia, perineal or transrectal approach to obtain systematic biopsy cores, specimen labeling and submission to pathology, post-procedure observation for bleeding or urinary retention, and discharge with post-biopsy instructions and follow-up for pathology results.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Office or other outpatient visit for the evaluation and management of a new or established patient | Use when procedure is performed in conjunction with an E/M service billed by the same provider and documentation supports separate E/M unrelated to the biopsy |
22 |